Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
Status:
Recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
This study will seek to enroll immunocompromised patients with Lower Tract parainfluenza
infection.
It also contains a sub-study to enroll patients with severe COVID-19.